Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novelion Therapeutics Inc (NVLN.TO)

Novelion Therapeutics Inc (NVLN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 247,123
  • Shares Outstanding, K 18,932
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta -0.39
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.86
Trade NVLN.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -6.06
  • Most Recent Earnings $-1.32 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend 19.576 on 06/28/13
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.12 +1.37%
on 05/03/17
14.47 -8.09%
on 04/04/17
-1.16 (-8.02%)
since 04/03/17
3-Month
13.12 +1.37%
on 05/03/17
16.35 -18.65%
on 03/10/17
+0.10 (+0.76%)
since 02/03/17

Business Summary

Novelion Therapeutics Inc is a biopharmaceutical company. It is engaged in developing patient care facility and providing services for people suffering from rare diseases like lipodystrophy, leber congenital amaurosis, and retinitis pigmentosa. Novelion, Aegerion, JUXTAPID, LOJUXTA, MYALEPT and MYALEPTA...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 13.91
1st Resistance Point 13.61
Last Price 13.30
1st Support Level 13.06
2nd Support Level 12.81
3rd Support Level N/A

See More

52-Week High 16.35
Fibonacci 61.8% 14.18
Fibonacci 50% 13.52
Last Price 13.30
Fibonacci 38.2% 12.85
52-Week Low 10.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar